| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| Cost of Revenue | $5.2M | — |
| R&D Expense | $57.9M | -0.2% |
| SG&A Expense | $159.3M | +139.0% |
| Operating Income | -$179.8M | -44.2% |
| Income Tax | $0 | — |
| Net Income | -$187.1M | -43.5% |
| EPS (Basic) | -$4.60 | -32.6% |
| EPS (Diluted) | -$4.60 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $200.8M | +132.3% |
| Accounts Receivable | $37.7M | — |
| Inventory | $4.3M | — |
| Current Assets | $245.6M | +183.9% |
| Total Assets | $331.5M | +277.6% |
| Current Liabilities | $96.6M | +318.6% |
| Long-term Debt | $94.3M | +92.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$116.5M | -7.7% |
| Capital Expenditures | $702K | +128.3% |
| Investing Cash Flow | -$53.7M | — |
| Financing Cash Flow | $284.6M | +2457.0% |
| Free Cash Flow | -$117.2M | -8.0% |
| Total Liabilities |
| $221.9M |
| +207.6% |
| Stockholders' Equity | $109.6M | +600.9% |